ArticleOncogene2008

Low-dose metronomic cyclophosphamide treatment mediates ischemia-dependent K-ras mutation in colorectal carcinoma xenografts.

S Shahrzad et al.PubMed ↗Publisher ↗

No numbers read from the abstract.